Mackay Shields LLC Denali Therapeutics Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$50.3 - $78.44 $1.13 Million - $1.76 Million	-22,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$53.8 - $81.53 $796,240 - $1.21 Million	-14,800 Reduced 39.78%	22,400 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $1.37 Million - $3.48 Million	37,200 New	37,200 $3.12 Million
Q2 2020 Jul 31, 2020	SELL	$16.01 - $28.82 $307,392 - $553,344	-19,200 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$14.2 - $27.98 $272,640 - $537,216	19,200 New	19,200 $337,000

228

120M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.